Senores Pharmaceuticals Ltd

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

10:29 AM, 17th Feb 2026

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on February 16 2026 for Renosen Pharmaceuticals Pvt Ltd

Senores Pharmaceuticals Ltd

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

More Senores Pharmaceuticals Ltd Announcements